Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Polk

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Archives of Surgery (Chicago, Ill. : 1960)|March 1, 1983
Gentamicin and tobramycin penetration into burn eschar. Pharmacokinetics and microbiological effectsR E Polk, C G Mayhall, J Smith, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1984
Cefmenoxime pharmacokinetics in patients with renal insufficiencyR E Polk, D A Sica, T M Kerkering, et al.
The Journal of Infectious Diseases|March 1, 1989
The role of the pharmacist in antimicrobial agent therapyS L Barriere, M N Dudley, S F Kowalsky, et al.
Antimicrobial Agents and Chemotherapy|March 18, 2000
Pharmacokinetic interaction between amprenavir and clarithromycin in healthy male volunteersD F Brophy, D S Israel, A Pastor, et al.
Pharmacotherapy|December 22, 1999
Pharmacokinetic interaction between ketoconazole and amprenavir after single doses in healthy menR E Polk, M A Crouch, D S Israel, et al.
Antimicrobial Agents and Chemotherapy|April 17, 2001
Tolerance and pharmacokinetic interactions of rifabutin and azithromycinR Hafner, J Bethel, H C Standiford, et al.
Antimicrobial Agents and Chemotherapy|February 13, 2001
Pharmacokinetic Interaction between amprenavir and rifabutin or rifampin in healthy malesR E Polk, D F Brophy, D S Israel, et al.
Journal of Clinical Pharmacology|April 18, 2001
Metabolic disposition and pharmacokinetics of [14C]-amprenavir, a human immunodeficiency virus type 1 (HIV-1) protease inhibitor, administered as a single oral dose to healthy male subjectsB M Sadler, G E Chittick, R E Polk, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1996
Effect of ciprofloxacin on the pharmacokinetics and pharmacodynamics of warfarinD S Israel, J Stotka, W Rock, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Archives of Surgery (Chicago, Ill. : 1960)|March 1, 1983
Gentamicin and tobramycin penetration into burn eschar. Pharmacokinetics and microbiological effectsR E Polk, C G Mayhall, J Smith, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1984
Cefmenoxime pharmacokinetics in patients with renal insufficiencyR E Polk, D A Sica, T M Kerkering, et al.
The Journal of Infectious Diseases|March 1, 1989
The role of the pharmacist in antimicrobial agent therapyS L Barriere, M N Dudley, S F Kowalsky, et al.
Antimicrobial Agents and Chemotherapy|March 18, 2000
Pharmacokinetic interaction between amprenavir and clarithromycin in healthy male volunteersD F Brophy, D S Israel, A Pastor, et al.
Pharmacotherapy|December 22, 1999
Pharmacokinetic interaction between ketoconazole and amprenavir after single doses in healthy menR E Polk, M A Crouch, D S Israel, et al.
Antimicrobial Agents and Chemotherapy|April 17, 2001
Tolerance and pharmacokinetic interactions of rifabutin and azithromycinR Hafner, J Bethel, H C Standiford, et al.
Antimicrobial Agents and Chemotherapy|February 13, 2001
Pharmacokinetic Interaction between amprenavir and rifabutin or rifampin in healthy malesR E Polk, D F Brophy, D S Israel, et al.
Journal of Clinical Pharmacology|April 18, 2001
Metabolic disposition and pharmacokinetics of [14C]-amprenavir, a human immunodeficiency virus type 1 (HIV-1) protease inhibitor, administered as a single oral dose to healthy male subjectsB M Sadler, G E Chittick, R E Polk, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1996
Effect of ciprofloxacin on the pharmacokinetics and pharmacodynamics of warfarinD S Israel, J Stotka, W Rock, et al.
Pageof 6